Life Edit Therapeutics

Clare Murray, Ph.D., Senior Vice President, Corporate Development and Operations

April 13 | 2:30pm | Dark Horse Consulting Ballroom 

Durham, NC


Life Edit Therapeutics, an ElevateBio company, has a mission to deliver any edit, anywhere to pave the way to faster and safer gene editing therapeutics that cure disease and improve patient lives. We have developed a gene editing platform with unique RNA-guided nucleases (RGNs), base editors, and next-gen editing capabilities which we have validated both ex vivo in a number of relevant cell types, and in vivo in liver and CNS. Life Edit is developing a pipeline of ex vivo edited cell therapies and in vivo gene editing therapies, both wholly owned and through partnerships.

By using this website you agree to accept our Privacy Policy and Terms & Conditions